Laporan Laba Rugi 002940 - TTM - Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Zhejiang AngLiKang Pharmaceutical CO.,LTD. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2022 01-01	2022 03-31	2022 06-30	2022 09-30	2023 01-01	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31
Revenue	1,247	1,290	1,303	1,315	1,358	1,380	1,400	1,450	1,457	1,568	1,655	1,708	1,692	1,621	1,604	1,630	1,560	1,513	1,451
Change (%)		3.39	1.01	0.98	3.26	1.63	1.40	3.62	0.43	7.68	5.50	3.22	-0.92	-4.24	-1.02	1.62	-4.27	-3.03	-4.13
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	247	321	382	411	504	488	510	578	565	675	773	826	893	914	929	961	939	925	890
Change (%)		30.25	18.97	7.44	22.86	-3.26	4.58	13.31	-2.27	19.41	14.56	6.80	8.12	2.35	1.69	3.43	-2.35	-1.41	-3.83
% of Revenue	19.77	24.91	29.34	31.21	37.14	35.35	36.46	39.87	38.80	43.03	46.72	48.34	52.75	56.38	57.93	58.96	60.14	61.15	61.34

Gross Operating Profit	1,001	968	921	905	854	892	889	872	891	894	882	882	800	707	675	669	622	588	561
Change (%)		-3.23	-4.94	-1.71	-5.64	4.51	-0.34	-1.93	2.22	0.24	-1.34	0.08	-9.37	-11.60	-4.52	-0.88	-7.03	-5.49	-4.60
% of Revenue	80.23	75.09	70.66	68.79	62.86	64.65	63.54	60.13	61.20	56.97	53.28	51.66	47.25	43.62	42.07	41.04	39.86	38.85	38.66

SG&A	781	748	696	678	643	674	660	638	641	631	617	572	492	395	330	292	273	274	266
Change (%)		-4.22	-6.98	-2.60	-5.17	4.80	-2.10	-3.21	0.41	-1.62	-2.17	-7.24	-14.04	-19.81	-16.24	-11.69	-6.35	0.16	-2.78
% of Revenue	62.63	58.02	53.43	51.54	47.33	48.81	47.13	44.02	44.01	40.21	37.28	33.51	29.07	24.34	20.60	17.90	17.51	18.09	18.35

R&D	49	44	45	49	52	53	56	69	83	113	119	127	145	143	172	191	209	214	217
Change (%)		-10.20	2.07	8.42	6.08	2.03	6.44	23.90	19.20	36.32	5.35	7.17	13.78	-0.91	19.76	11.28	9.52	2.42	1.27
% of Revenue	3.92	3.40	3.44	3.69	3.79	3.81	4.00	4.78	5.67	7.18	7.17	7.45	8.55	8.85	10.70	11.72	13.41	14.17	14.96

OpEx	1,074	1,128	1,151	1,171	1,233	1,229	1,239	1,301	1,303	1,427	1,501	1,514	1,516	1,457	1,445	1,434	1,401	1,395	1,356
Change (%)		5.05	2.09	1.70	5.33	-0.34	0.84	4.96	0.20	9.45	5.24	0.86	0.14	-3.92	-0.80	-0.81	-2.27	-0.46	-2.79
% of Revenue	86.06	87.44	88.38	89.01	90.80	89.04	88.55	89.69	89.49	90.96	90.73	88.66	89.60	89.90	90.10	87.95	89.79	92.18	93.46

Operating Income	174	162	151	145	125	151	160	150	153	142	153	194	176	164	159	196	159	118	95
Change (%)		-6.86	-6.51	-4.52	-13.55	21.01	5.99	-6.73	2.42	-7.42	8.18	26.27	-9.13	-7.02	-2.97	23.69	-18.87	-25.71	-19.90
% of Revenue	13.94	12.56	11.62	10.99	9.20	10.96	11.45	10.31	10.51	9.04	9.27	11.34	10.40	10.10	9.90	12.05	10.21	7.82	6.54

Interest Expense		-0	-0	-0	-0	-0	-1	-2	-4	-6	-8	-10	-13	-14	-17	-18	-17	-17	-15
Change (%)			45.64	-11.21	-18.08	102.58	53.46	304.69	79.50	55.96	29.44	25.30	21.32	12.57	18.11	6.18	-2.72	-3.96	-8.50
% of Revenue		-0.01	-0.02	-0.02	-0.01	-0.03	-0.04	-0.16	-0.28	-0.41	-0.50	-0.61	-0.74	-0.87	-1.04	-1.09	-1.11	-1.10	-1.05

Net Income	146	164	155	144	115	120	126	133	153	127	135	152	129	138	120	102	79	80	68
Change (%)		12.06	-5.50	-6.77	-20.48	4.50	5.26	5.72	14.66	-16.76	6.27	12.67	-15.49	7.42	-13.62	-14.46	-23.21	2.32	-15.33
% of Revenue	11.71	12.69	11.88	10.96	8.44	8.68	9.01	9.20	10.50	8.12	8.18	8.92	7.61	8.54	7.45	6.27	5.03	5.31	4.69

Source: Capital IQ

Zhejiang AngLiKang Pharmaceutical CO.,LTD. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)